NetTargets Inc.
21 Apr 2023
NetTargets will be participating at BIO KOREA 2023, being held from May 10th to 12th (NetTargets booth no. Q25). Our CITO, Jehoon Song, will also be presenting at the conference during Session 15 (AI-Based Drug Discovery from Basic Research up to Preclinical Development). We encourage you to attend the session if the topic interests you.
Title: Discovery of Mechanism-Based Drug Targets through Integration of Artificial Intelligence and Systems Biology Schedule: Thursday, May 11, 2023,10:40-11:20 AM KST
Please feel free to visit our booth (Q25) or contact us if you have any inquiries or would like to discuss our technology. Thank you for your interest, and we hope to see you at BIO KOREA 2023.
* BIO KOREA 2023 Webpage : biokorea.org
NetTargets will contribute its proprietary AI-based systems biology modeling technology to WOOJUNGBIO’s Open Innovation Project. By enabling quantitative simulation of biological responses and prediction of drug mechanisms, we are helping to shape a next-generation bioevaluation platform in the era of AI transformation.
NetTargets has been selected as one of the top 10 semifinalists among hundreds of drug discovery startups worldwide. The AI Discovery Award is an annual recognition by Nebius AI, a European AI-centric public cloud provider with global reach.